3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study assesses the effect of a further 3 years adjuvant treatment with anastrozole vs. an
untreated control group after initial 5 years of adjuvant hormone-therapy.